Leveraging the University of California Health Data Warehouse enabled a realworld analysis of 6,871 patients with primary colon cancer and rigorous adjustment strategies to probe whether GLP1 RA exposure relates to fiveyear mortality. At the end of the study, researchers found that participants with colon cancer taking GLP-1 medications had a 15.5% mortality risk within 5 years, compared to 37.1% in participants not taking the drugs
Both metformin and long-term use of proton pump inhibitors have been linked to reduced B12, and the same goes for many people past 50
Albers AC, Gutmann DH
Sotorasib binds covalently to the switch II pocket formed by the KRAS G12C mutation, inhibiting KRAS activity and overcoming resistance
Its all tailored to your body, your cycle, and your long-term health goals
Dumping syndrome and GLP-1 side effects can have some overlapping symptoms, such as nausea, diarrhoea, dizziness, sweating, and weakness after meals